Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genesco (GCO) Common Equity (2016 - 2025)

Historic Common Equity for Genesco (GCO) over the last 16 years, with Q4 2025 value amounting to $513.8 million.

  • Genesco's Common Equity fell 60.53% to $513.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was $513.8 million, marking a year-over-year decrease of 60.53%. This contributed to the annual value of $547.0 million for FY2025, which is 424.23% down from last year.
  • Latest data reveals that Genesco reported Common Equity of $513.8 million as of Q4 2025, which was down 60.53% from $506.4 million recorded in Q3 2025.
  • Genesco's 5-year Common Equity high stood at $607.0 million for Q1 2023, and its period low was $506.4 million during Q3 2025.
  • Moreover, its 5-year median value for Common Equity was $559.9 million (2022), whereas its average is $558.4 million.
  • Over the last 5 years, Genesco's Common Equity had its largest YoY gain of 2760.75% in 2021, and its largest YoY loss of 849.03% in 2021.
  • Quarter analysis of 5 years shows Genesco's Common Equity stood at $592.4 million in 2021, then dropped by 5.58% to $559.3 million in 2022, then decreased by 4.0% to $537.0 million in 2023, then dropped by 3.73% to $516.9 million in 2024, then fell by 0.61% to $513.8 million in 2025.
  • Its Common Equity stands at $513.8 million for Q4 2025, versus $506.4 million for Q3 2025 and $522.2 million for Q2 2025.